Table 2 Toxic effect incidences in sixty locally advanced breast cancer patients subjected to neoadjuvant docetaxel (75 mg/m2) and epirubicin (50 mg/m2) combination.
| Â | Toxicity (%) |
|---|---|
Alopecia | 100 |
Nausea and vomiting | 19.2 |
Neutropenia | 11.5 |
Febrile neutropenia | 3.8 |
Fever | 5.7 |
Diarrhea | 5.7 |
Mucositis | 3.8 |
Allergic reactions | 3.8 |
Asthenia | 1.9 |
Headache | 1.9 |